Development and preliminary validation of a pain measure specific to neuropathic pain

Bradley S. Galer, M. Jensen

Neurology · 1997 · 777 citations · 5 references

Concepts

TL;DR

Neuropathic pain syndromes are common in clinical practice and serve as pain models for new therapies, yet no dedicated pain scale exists for neuropathic pain. The study aims to develop and preliminarily validate the Neuropathic Pain Scale (NPS) to assess distinct pain qualities in neuropathic pain. The authors developed the NPS and conducted preliminary validation to evaluate its discriminant and predictive validity. The NPS items demonstrated discriminant and predictive validity, were sensitive to treatments affecting neuropathic pain, and support further development. NEUROLOGY 1997;48:332-338.

Abstract

Article abstract-Neuropathic pain syndromes are commonly seen in clinical practice and are frequently used as pain models in testing new therapies. However, no pain scale exists with the primary purpose to measure pain in neuropathic syndromes. This paper describes the development and preliminary validation of the Neuropathic Pain Scale (NPS), which is designed to assess distinct pain qualities associated with neuropathic pain. Results support the discriminant and predictive validity of the NPS items. Moreover, the NPS items appear to be sensitive to treatments known to impact neuropathic pain. These findings provide support for the further development of the NPS. <b>NEUROLOGY 1997;48: </b> 332-338

References

5